Skip to main content

and
  1. Article

    Open Access

    PROX1 is a predictor of survival for gliomas WHO grade II

    The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers ...

    T Elsir, M Qu, S G Berntsson, A Orrego, T Olofsson in British Journal of Cancer (2011)